Amgen (AMGN)
(Delayed Data from NSDQ)
$301.08 USD
+0.38 (0.13%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $300.02 -1.06 (-0.35%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 221 - 240 ( 429 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Hematology KOL Dinner Offers In-Depth Look Across ITP, PNH Landscapes
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Q2 Revenue Flat; KRAS Showing Efficacy in Colorectal Cancer - Hold
Provider: G.RESEARCH, LLC
Analyst: HE J
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department